DE69923829D1 - Zusammensetzung von nucleinsäuren und acemannan - Google Patents

Zusammensetzung von nucleinsäuren und acemannan

Info

Publication number: DE69923829D1
Authority: DE; Germany
Prior art keywords: acemannan; composition; nucleic acids; nucleic; acids
Prior art date: 1998-09-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69923829T

Other languages

English (en)

Inventor

Rubido Julio Cesar Aguilar

Gonzalez Verena Lucila Muzio

Nieto Gerardo Enrique Guillen

Arias Eduardo Penton

Angulo Maria De Jesus Leal

Diaz Dagmara Pichardo

Perez Enrique Iglesias

Buch Antonieta Herrera

Oquendo Belquis Sandez

Lasa Alexis Musacchio

Vazquez Dietagenes Quintana

Menendez Lissete Crombet

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Centro de Ingenieria Genetica y Biotecnologia CIGB

Original Assignee

Centro de Ingenieria Genetica y Biotecnologia CIGB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-07

Filing date

1999-09-03

Publication date

2005-03-31

1999-09-03 Application filed by Centro de Ingenieria Genetica y Biotecnologia CIGB filed Critical Centro de Ingenieria Genetica y Biotecnologia CIGB

2005-03-31 Application granted granted Critical

2005-03-31 Publication of DE69923829D1 publication Critical patent/DE69923829D1/de

2019-09-04 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

XOYXESIZZFUVRD-UVSAJTFZSA-M acemannan Chemical compound CC(=O)O[C@@H]1[C@H](O)[C@@H](OC)O[C@H](CO)[C@H]1O[C@@H]1[C@@H](O)[C@@H](OC(C)=O)[C@H](O[C@@H]2[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]3[C@H]([C@@H](O)[C@H](O[C@@H]4[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]5[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]6[C@H]([C@@H](OC(C)=O)[C@H](O[C@@H]7[C@H]([C@@H](OC(C)=O)[C@H](OC)[C@@H](CO)O7)O)[C@@H](CO)O6)O)[C@H](O5)C([O-])=O)O)[C@@H](CO)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](CO)O2)O)[C@@H](CO)O1 XOYXESIZZFUVRD-UVSAJTFZSA-M 0.000 title 1
229960005327 acemannan Drugs 0.000 title 1
150000007523 nucleic acids Chemical group 0.000 title 1
102000039446 nucleic acids Human genes 0.000 title 1
108020004707 nucleic acids Proteins 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
Virology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DE69923829T 1998-09-07 1999-09-03 Zusammensetzung von nucleinsäuren und acemannan Expired - Lifetime DE69923829D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CU1998126A CU22740A1 (es)	1998-09-07	1998-09-07	Formulación de ácidos nucleicos y acemanano
PCT/CU1999/000004 WO2000013704A1 (es)	1998-09-07	1999-09-03	Formulacion de acidos nucleicos y acemanano

Publications (1)

Publication Number	Publication Date
DE69923829D1 true DE69923829D1 (de)	2005-03-31

Family

ID=5459419

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69923829T Expired - Lifetime DE69923829D1 (de)	1998-09-07	1999-09-03	Zusammensetzung von nucleinsäuren und acemannan

Country Status (10)

Country	Link
US (1)	US6358933B1 (de)
EP (1)	EP1029549B1 (de)
CN (1)	CN1287493A (de)
AR (1)	AR020403A1 (de)
AT (1)	ATE289518T1 (de)
BR (1)	BR9906761A (de)
CA (1)	CA2308444A1 (de)
CU (1)	CU22740A1 (de)
DE (1)	DE69923829D1 (de)
WO (1)	WO2000013704A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7223739B1 (en)	1995-06-07	2007-05-29	Powderject Vaccines, Inc.	Adjuvanted genetic vaccines
US7022320B1 (en)	1999-02-09	2006-04-04	Powderject Vaccines, Inc.	Mycobacterium tuberculosis immunization
CA2389686A1 (en) *	1999-11-03	2001-05-10	Powderject Vaccines, Inc.	Adjuvanted genetic vaccines
US20090110702A1 (en)	2002-07-12	2009-04-30	The Johns Hopkins University	Mesothelin Vaccines and Model Systems and Control of Tumors
AU2003259109A1 (en) *	2002-07-12	2004-02-02	The Johns Hopkins University	Mesothelin vaccines and model systems
US9200036B2 (en)	2002-07-12	2015-12-01	The Johns Hopkins University	Mesothelin vaccines and model systems

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5106616A (en) *	1988-01-14	1992-04-21	Carrington Laboratories, Inc.	Administration of acemannan
ZA93216B (en) *	1992-01-17	1993-08-18	Solvay Animal Health Inc	Vaccine containing acemannan as an adjuvant.

1998
- 1998-09-07 CU CU1998126A patent/CU22740A1/es unknown
1999
- 1999-09-03 CA CA002308444A patent/CA2308444A1/en not_active Abandoned
- 1999-09-03 CN CN99801915A patent/CN1287493A/zh active Pending
- 1999-09-03 US US09/530,925 patent/US6358933B1/en not_active Expired - Fee Related
- 1999-09-03 EP EP99942707A patent/EP1029549B1/de not_active Expired - Lifetime
- 1999-09-03 AT AT99942707T patent/ATE289518T1/de not_active IP Right Cessation
- 1999-09-03 WO PCT/CU1999/000004 patent/WO2000013704A1/es active IP Right Grant
- 1999-09-03 BR BR9906761-7A patent/BR9906761A/pt not_active IP Right Cessation
- 1999-09-03 DE DE69923829T patent/DE69923829D1/de not_active Expired - Lifetime
- 1999-09-07 AR ARP990104496A patent/AR020403A1/es unknown

Also Published As

Publication number	Publication date
EP1029549B1 (de)	2005-02-23
CN1287493A (zh)	2001-03-14
WO2000013704A1 (es)	2000-03-16
EP1029549A1 (de)	2000-08-23
ATE289518T1 (de)	2005-03-15
US6358933B1 (en)	2002-03-19
CU22740A1 (es)	2002-02-28
BR9906761A (pt)	2000-10-03
CA2308444A1 (en)	2000-03-16
AR020403A1 (es)	2002-05-08

Publication	Publication Date	Title
DE69928195D1 (de)	2005-12-15	Komplettierung von Untrerdruck-Bohrlöchern
DE69831755D1 (de)	2006-02-09	Optoakustische kontrastmittel und anwendungsverfahren
DE69814069D1 (de)	2003-06-05	Neuartige form von s-omeprazol
DE69835020D1 (de)	2006-08-03	Plasmabrenner und verwendungsverfahren dieses plasmabrenners
PT1108039E (pt)	2008-07-11	Genes de alongases e suas utilizações
ID29021A (id)	2001-07-26	Komposisi galantamina pelepasan terkontrol
ATE351910T1 (de)	2007-02-15	Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
DE69431719D1 (de)	2002-12-19	Hybridisierung und sequenzierung von nukleinsäuren
MA26668A1 (fr)	2004-12-20	ACTIVATEURS DE hPPARy ET hPPARa
IL132704A0 (en)	2001-03-19	Methods and compositions for the selective modification of nucleic acids
DE69732881D1 (de)	2005-05-04	Verwendung von zusammensetzungen mit stabilisierten enzymen
DE69832490D1 (de)	2005-12-29	Vervielfältigung von nukleinsäuren
EP1015470A4 (de)	2008-05-07	Zusammensetzung und herstellung zum fordern von nukleinsauren
EP1019083A4 (de)	2001-03-28	Verfahren und zusammensetzungen zur selektiven modifizierung von nukleinsäuren
ID28728A (id)	2001-06-28	Komposisi dan proses pengkrepan
DE69930647D1 (de)	2006-05-18	Struktur-analoga von amin-basen und nucleosiden
ID24196A (id)	2000-07-13	Komposisi dan penggunaan
DE69838832D1 (de)	2008-01-24	Zusammensetzung von vermischbaren Pigmenten
DE69805853D1 (de)	2002-07-11	Modifizierte lithium-vanadium-oxidelektrodenmaterialien, produkte und verfahren
FI980246A (fi)	1998-08-11	Menetelmä keittimen käyttämiseksi ja keitin
DE69921311D1 (de)	2004-11-25	Vervielfältigung von nukleinsäuren
DE69907146T2 (de)	2004-01-29	Direkte oxidation von cycloalkanen
DE59708905D1 (de)	2003-01-16	Injektionsformulierungen von avermectinen und milbemycinen
DE69915591D1 (de)	2004-04-22	Zusammensetzungen von 1,1,1,3,3-pentafluorpropan und trans-1,2-dichlorethylen
DE69816046D1 (de)	2003-08-07	Zusammensetzung auf basis von hexanitrohexaazaisowurtizitan und hexanitrohexaazaisowurtizitan enthaltende sprengstoffzusammensetzung

Legal Events

Date	Code	Title	Description
2006-01-26	8332	No legal effect for de